Pharmacotherapy in Tobacco Cessation: A Narrative Review.
and nicvax
anxiolytics
bupropion
clonidine
mecamylamine
naltrexone
nortriptyline
varenicline
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
23
09
2022
accepted:
16
02
2023
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
A chronic, recurring illness, known as nicotine addiction and dependence, is defined by a person's dependence on the substance up to the extent that their normal day-to-day activities are compromised in the absence of the substance. This paper will highlight first-line smoking cessation treatments, such as nicotine replacement therapy (NRT), bupropion, and varenicline, and second-line medications, such as clonidine, nortriptyline, anxiolytics, mecamylamine, naltrexone, and NicVAX (Nabi Biopharmaceuticals, Rockville, MD, USA). NRT offers many options for nicotine delivery methods, comprising nicotine gum, rapid-release gum, lozenges, transdermal patches, high-dose nicotine patches, oral inhalers, nasal sprays, electronic nicotine delivery systems (ENDS), and sublingual tablets. Pharmacotherapies for quitting tobacco should lessen withdrawal symptoms and stop nicotine's reinforcing effects without having too many side effects.
Identifiants
pubmed: 36938244
doi: 10.7759/cureus.35086
pmc: PMC10023046
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e35086Informations de copyright
Copyright © 2023, Pajai et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann Pharmacother. 1993 Sep;27(9):1025-8
pubmed: 8219431
Nicotine Tob Res. 2015 Jan;17(1):26-33
pubmed: 25082830
Front Hum Neurosci. 2020 Sep 08;14:314
pubmed: 33100983
JAMA. 2006 Jul 5;296(1):64-71
pubmed: 16820548
Psychopharmacology (Berl). 2017 Mar;234(5):781-792
pubmed: 28028600
Tob Control. 2022 Mar;31(2):129-137
pubmed: 35241576
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619875925
pubmed: 31533544
Clin Pharmacol Ther. 2008 Mar;83(3):436-42
pubmed: 17687275
Pharmacol Biochem Behav. 1983 Dec;19(6):1011-20
pubmed: 6657719
Open Access Maced J Med Sci. 2019 Oct 11;7(21):3659-3666
pubmed: 32010395
Cochrane Database Syst Rev. 2000;(4):CD002849
pubmed: 11034774
Arch Intern Med. 2009 Jun 8;169(11):1028-34
pubmed: 19506172
J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365
pubmed: 30527452
J Addict Med. 2020 Jan/Feb;14(1):69-77
pubmed: 31658113
Br J Clin Pharmacol. 2014 Feb;77(2):324-36
pubmed: 23488726
J Family Med Prim Care. 2020 Jun 30;9(6):2615-2620
pubmed: 32984096
Nicotine Tob Res. 2002 Nov;4(4):441-50
pubmed: 12521403
Cleve Clin J Med. 2021 Jul 1;88(7):393-404
pubmed: 34210714
Ther Adv Psychopharmacol. 2016 Apr;6(2):99-144
pubmed: 27141292
Chest. 2006 Aug;130(2):334-42
pubmed: 16899830
Am J Health Syst Pharm. 2014 Apr 15;71(8):634-8
pubmed: 24688036
J Matern Fetal Neonatal Med. 2009 Sep;22(9):751-8
pubmed: 19526424
J Assoc Physicians India. 2012 Feb;60 Suppl:53-6
pubmed: 23155814
Int J Health Sci (Qassim). 2016 Jul;10(3):425-35
pubmed: 27610066
Tob Induc Dis. 2020 May 08;18:41
pubmed: 32435175
Cochrane Database Syst Rev. 2004;(3):CD000058
pubmed: 15266422
Cas Lek Cesk. 2004;143(11):781-3
pubmed: 15628577
BMJ Open. 2014 Mar 14;4(3):e004393
pubmed: 24633528
NIDA Res Monogr. 1984 Mar;49:239-46
pubmed: 6434966
Lancet. 2016 Jun 18;387(10037):2507-20
pubmed: 27116918
CA Cancer J Clin. 2005 Sep-Oct;55(5):281-99; quiz 322-3, 325
pubmed: 16166074
Pharmacotherapy. 2018 Feb;38(2):235-258
pubmed: 29250815
Addiction. 2005 Mar;100(3):317-26
pubmed: 15733245
Pharmacol Biochem Behav. 1983 Dec;19(6):1021-6
pubmed: 6657720
J Thorac Dis. 2020 Jul;12(7):3857-3865
pubmed: 32802467
Pharmacol Biochem Behav. 2009 Jan;91(3):380-4
pubmed: 18762208
Addiction. 2014 Aug;109(8):1252-9
pubmed: 24894625
Indian J Psychiatry. 2014 Jan;56(1):87-95
pubmed: 24574567
Nicotine Tob Res. 2007 Feb;9(2):233-40
pubmed: 17365754